Vivo Capital VIII LLC 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-28 4:30 pm Purchase |
2020-10-20 | 13G | Aligos Therapeutics, Inc. ALGS |
Vivo Capital VIII LLC | 141,881 10.500% |
141,881 (New Position) |
Filing |